Janssen Announces European Commission Approval of JULUCA®▼ (dolute
Dolutegravir/rilpivirine, the result of a collaboration with ViiV Healthcare...
2018-05-22
文传商讯
Janssen Announces Positive CHMP Opinion for JULUCATM▼ (dolutegravir/ri
If approved, stable, virologically suppressed adults living with HIV-1 could...
2018-03-28
文传商讯
European Commission Approves Symtuza for the Treatment of HIV-1 In Adul
Symtuza is the only darunavir-based single-tablet regimen (STR) approved for...
2017-09-28
文传商讯
